Palvella Puts U.S. DSAP Population at 154,986 in New Posters
Palvella Therapeutics posters estimate 154,986 U.S. patients with disseminated superficial actinic porokeratosis, sharpening the epidemiological picture for the rare skin disease.
Topic
Epidemiology
Topic
Epidemiology
Florida's Melanoma Burden Concentrated in Older Adults, FAU Reports
Florida Atlantic University finds melanoma cases and deaths in Florida peak among older adults, highlighting late-detection risk…
Skin Cancer Burden Projected to Surge Through 2050
Skin cancer incidence is projected to climb through 2050, with low- and middle-income regions facing the steepest rise, straining…
National Eczema Association Releases First National, State-Level AD Report
The National Eczema Association has published the first comprehensive national and state-level report on atopic dermatitis, creat…
EADV 2026 Presenters Link Climate Shifts to Skin Disease Burden
EADV 2026 presenters link climate change to shifting skin disease patterns worldwide, with implications for incidence surveillanc…
National Eczema Association Releases First National and State-Level AD Report
The National Eczema Association has published the first comprehensive report on atopic dermatitis covering both national and stat…
UK Melanoma Cases Hit Record Level, Analysis Finds
An analysis reported by The Guardian finds melanoma skin cancer cases in the UK have reached a record level, underscoring pressur…
Atopic Dermatitis Raises Herpes Zoster Risk 28% in 13-Million-Person UK Cohort
A UK cohort of 13.4 million people found a 28% higher herpes zoster risk in atopic dermatitis, rising to an aHR of 2.33 in severe…